Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
Gepubliceerd in: | PLoS One 17(2022)10, S. e0274315 |
---|---|
Hoofdauteurs: | Hawchar, Fatime (Auteur), Tomescu, Dana (Auteur), Henzler, Dietrich (Auteur) |
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
2022
|
Onderwerpen: | |
Online toegang: | https://doi.org/10.1371/journal.pone.0274315 |
Gerelateerde Items: | In:
PLoS One |
Gelijkaardige items
-
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
door: Köhler, Thomas, et al.
Gepubliceerd in: (2021) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
door: Köhler, Thomas, et al.
Gepubliceerd in: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
door: Köhler, Thomas, et al.
Gepubliceerd in: (2021) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
door: Schultz, Philipp, et al.
Gepubliceerd in: (2021) -
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry
door: Al-Batran, Salah-Eddin, et al.
Gepubliceerd in: (2021)